A study recently published in Annals of the Rheumatic Diseases shows promise for potential new therapies to prevent bone loss and bone destruction in patients with rheumatoid arthritis (RA).
Our Commitment to Research
The ACR has a wide range of programs to support investigations in rheumatology
REF Investigators’ Meeting Brings Researchers Together to Search for RA Cure
REF Investigators’ Meeting brings researchers together to search for RA cure
ACR and EULAR Debut New RA Classification Criteria in August
The complex development process focused on earlier detection and treatment
Within Our Reach: Collaborating to Find a Cure for RA
Research is critically important to find cures and accelerate patient care for the millions who suffer from arthritis and rheumatic disease. Despite its prevalence in the population and recent treatment advances, rheumatoid arthritis (RA) remains an incurable disease and receives disproportionately less research funding from federal sources than most other autoimmune diseases. This is precisely why the ACR Research and Education Foundation (REF) launched Within Our Reach: Finding a Cure for Rheumatoid Arthritis to directly invest in the types of innovative research not being done elsewhere in the country.
Recent Study Improves Understanding of Preclinical Rheumatoid Arthritis
A study recently published in Arthritis Care & Research (AC&R) reveals a novel approach for the study of preclinical rheumatoid arthritis (RA). The investigators conducting the study sought to determine if these RA-related biomarkers could also be found in healthy subjects in order to investigate relationships between genetic and environmental factors and the presence of these biomarkers. Their goal is to study how these biomarkers evolve.
Cardiovascular Disease Risk High in RA Patients
High incidence of metabolic disease and concurrent inflammation increases risk
Cobra Therapy for Rheumatoid Arthritis
Initial high-dose therapy may help patients seeking relief
Immune System No Longer Autonomous?
Evolving model has implications for novel therapies
Within Our Reach–Funded Study Finds Increased Depression Risk Among Some RA Patients
A study recently published in Arthritis & Rheumatism found that a cohort of patients from multiethnic backgrounds who all had rheumatoid arthritis (RA) had nearly double the rate of depressive symptoms compared with middle-class white patients with RA.1 The study also examined predictors of depression, and concluded that physical disability—not acute disease activity—is the principal predictor of depression in patients with RA.
- « Previous Page
- 1
- …
- 66
- 67
- 68
- 69
- 70
- …
- 74
- Next Page »